Jounce Therapeutics, Inc.

JNCE · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$150,572$95,529$147,493$53,241
Short-Term Investments$38,970$83,037$58,985$115,602
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$7,689$12,261$4,913$4,854
Total Curr. Assets$197,231$190,827$211,391$173,697
Property Plant & Equip (Net)$12,317$16,759$22,192$28,287
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$41,657$6,710$1,601
Tax Assets$0$0$0$0
Other NC Assets$3,002$3,453$3,943$2,297
Total NC Assets$15,319$61,869$32,845$32,185
Other Assets$0$0$0$0
Total Assets$212,550$252,696$244,236$205,882
Liabilities
Payables$2,095$1,674$2,036$2,460
Short-Term Debt$4,150$3,695$3,271$2,901
Tax Payable$0$0$0$0
Deferred Revenue$0$13,467$1,931$8,907
Other Curr. Liab.$17,323$62$12,086$132
Total Curr. Liab.$23,568$18,898$19,324$14,400
LT Debt$5,870$9,993$13,618$16,889
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$5,870$9,993$13,618$16,889
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$29,438$28,891$32,942$31,289
Equity
Pref Stock$0$0$0$0
Common Stock$51$51$42$34
Retained Earnings-$292,792-$241,873-$151,001-$107,159
AOCI-$677-$238-$17$54
Other Equity$476,530$465,865$362,270$281,664
Total Equity$183,112$223,805$211,294$174,593
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$212,550$252,696$244,236$205,882
Net Debt-$140,552-$81,841-$130,604-$33,451
Jounce Therapeutics, Inc. (JNCE) Financial Statements & Key Stats | AlphaPilot